Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Alzheimer's DiseaseMild Cognitive Impairment
Interventions
OTHER

Gastro-retentive zinc cysteine tablet

Oral, one tablet, once daily with water for 6 months.

OTHER

Tablet identical physically to active comparator containing some lactose

Oral, once daily, with water, 6 months.

Trial Locations (3)

33756

Neuroscience Research Unit, Clearwater

34668

The Cottages, Port Richey

34691

ATIT Neurology, Holiday

Sponsors
All Listed Sponsors
lead

Adeona Pharmaceuticals

INDUSTRY

NCT01099332 - Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease | Biotech Hunter | Biotech Hunter